Best Koyfin Alternative: Cheaper, Broader Coverage

The best Koyfin alternative for fundamental stock screening is ScreenerHero. It costs €29/month, covers US, Canadian, and all European exchanges including microcaps, and is built entirely around the screening workflow rather than dashboards and charting. For investors who use 80% of their time in a screener and 20% in charts, switching from Koyfin saves $10–50/month while gaining European small-cap coverage that Koyfin lacks.

Last updated: July 2026.

Why Koyfin users look for alternatives

Koyfin ranked first in Financial Analytics on G2 in Winter 2026. It is a genuinely well-built product. But three patterns drive users to look for alternatives:

1. You're paying for a dashboard you mostly ignore. Koyfin's core value proposition is institutional-grade financial dashboards — customizable watchlists, macro overlays, earnings calendars, historical financial statements going back 10 years. If your workflow is "open screener → filter → build shortlist → close," you are paying $39–79/month for infrastructure you don't use.

2. European microcap coverage has documented gaps. Koyfin covers 100,000+ global securities in principle. In practice, European small-cap and microcap fundamental data — particularly for alternative markets like Euronext Growth Paris, Nasdaq First North, and EGM Milan — is inconsistently populated. Stocks are listed; filter results often come back empty or stale.

3. The price scales with use cases you may not have. Koyfin Plus is $39/month. Koyfin Pro is $79/month for mutual funds, transcripts, and custom formulas. These are legitimate features — but investors who primarily screen for equities are paying for research terminal capabilities that a pure screener doesn't need.

Koyfin vs. alternatives: comparison table

Data as of June 2026.

The main alternatives to Koyfin in 2026

ScreenerHero — best for systematic fundamental screening

ScreenerHero is the closest screener-for-screener Koyfin replacement if your primary workflow is filtering stocks by fundamental criteria. It covers:

• US (NYSE, NASDAQ), Canada (TSX, TSXV), and all major European exchanges
• Alternative markets: Euronext Growth Paris, Nasdaq First North, EGM Milan, GPW NewConnect
• Fundamental filters: P/E, P/B, EV/EBITDA, ROE, ROIC, FCF yield, operating margin, revenue growth, dividend yield, debt/equity
• Heatmap view for at-a-glance market orientation

Best for: Investors who screen European (and US/Canadian) equities by fundamental criteria. Faster, cheaper, and broader in European coverage than Koyfin.

What you lose: 10-year historical statements, macro dashboards, earnings transcripts.

Price: €29/month Pro. Free with no account for core screening.

TIKR Pro — best for 20-year historical depth

TIKR's main advantage over Koyfin is historical data depth: 20 years of financial statements vs. Koyfin's 10. For investors who need to verify a company's long-term track record, TIKR Pro is the better research tool.

Best for: Deep-dive research on individual companies with long track records. The historical depth advantage is real and matters for specific strategies (e.g., Buffett-style franchise analysis, 15-year ROIC persistence checks).

What you lose vs. Koyfin: Macro dashboards. Better charting integration.

Price: $40–55/month. Similar to or more expensive than Koyfin Plus.

Finviz Elite — best Koyfin replacement for US-only screeners

If your screening universe is exclusively US equities, Finviz Elite at $39.50/month gives you deeper US fundamental and technical coverage than Koyfin — 60+ filters, insider data, institutional ownership, after-hours data, and real-time quotes.

Best for: US-only investors who want the best US screener available.

What you lose: European and Canadian coverage; macro dashboards.

Stock Analysis (stockanalysis.com) — best free Koyfin alternative

For investors who primarily use Koyfin's financial statement lookup rather than its screener, Stock Analysis covers 120,000+ stocks with full financial statements, estimates, and historical data — free. The screener is functional but less sophisticated than paid alternatives.

Best for: Investors who used Koyfin as a free financial data lookup. Not a screener-first replacement.

Koyfin vs. ScreenerHero: a direct comparison for screening workflows

If your Koyfin workflow is:

1. Open screener
2. Set fundamental filters (P/E, ROE, margin, growth)
3. Get a list of candidates
4. Open individual stock pages for basic metrics
5. Close and start research elsewhere

…then Koyfin's differentiating features (macro dashboards, 10-year statements, custom formulas) are not part of your workflow. You are paying $39/month for a screener that lives inside a platform designed for broader use cases.

The specific comparison on the screener function:

Koyfin screener strengths:

• 500+ screening metrics (more than most dedicated screeners)
• Percentile rank filters — screen for stocks in the top decile of a metric globally
• Integrated with the broader Koyfin research workflow if you do use it

ScreenerHero screener strengths:

• European small-cap and microcap coverage that Koyfin lacks
• Free no-account tier for the core screener
• Heatmap view across European markets by sector and country
• €10/month cheaper than Koyfin Plus at equivalent screener depth

The decision is not which screener has more filters — it is whether the 500+ Koyfin filters serve your actual screening process, and whether Koyfin's European data gaps affect the markets you care about.

When Koyfin is still the right choice

There are genuine use cases where Koyfin is the better tool:

If macro overlays are part of your investment process. Koyfin's macro dashboards — GDP growth, central bank rates, yield curves, credit spreads — are genuinely useful for top-down investors who start with macro views before selecting individual stocks. No screener-focused alternative replicates this.

If you need 10-year financial statement history in the same platform. For DCF-focused investors who build 10-year projection models from historical data, Koyfin's integrated statements save time compared to switching between a screener and a separate data source.

If percentile rank filters matter to your process. Koyfin's ability to screen for "top 20% globally by ROIC" is a quantitative filter that raw metric screeners don't replicate. If your strategy is factor-based and percentile-driven, Koyfin's filter approach is genuinely different.

Frequently asked questions

Is there a free Koyfin alternative?

Stock Analysis (stockanalysis.com) is the closest free alternative for financial statement data. ScreenerHero's core screener is free without an account — a free Koyfin screener equivalent for European and US equities.

What is Koyfin best for?

Koyfin is best for investors who need a single platform covering financial screening, macro data, historical statements, and portfolio tracking. It is a research terminal, not just a screener. Users who primarily screen stocks and do not use the macro or historical features are paying for capabilities they don't need.

Does Koyfin cover European stocks well?

Koyfin covers European large and mid-cap stocks adequately. European small-cap and microcap fundamental data — particularly for Euronext Growth, Nasdaq First North, EGM Milan, and GPW NewConnect — has documented gaps where filter results are empty or stale. For investors focused on European smaller companies, dedicated European screeners have better data quality.

Is ScreenerHero cheaper than Koyfin?

ScreenerHero Pro at €29/month (~$31) is $8–10/month cheaper than Koyfin Plus ($39) and $48–50/month cheaper than Koyfin Pro ($79). For investors using Koyfin primarily as a screener, the cost difference is meaningful without functional trade-offs in the screening workflow itself.

Which has better European coverage: Koyfin or ScreenerHero?

ScreenerHero has broader and more reliable European coverage, particularly for small-cap and alternative market names (Euronext Growth, First North, EGM, NewConnect). Koyfin covers European large and mid-caps well but has gaps in the smaller company coverage that European equity investors often care about most.

Try the screener → — free, no account required. Covers US, Canada, and all major European exchanges including microcaps. Pro at €29/month.